|source|target|predicate|source_label|target_label
0|DrugCentral:3317|UniProtKB:P01375|biolink:molecularly_interacts_with|lenalidomide|TNF
1|DrugCentral:3317|UniProtKB:P19526|biolink:interacts_with|lenalidomide|GABRR1
2|ttd.drug:D0M4KE|UniProtKB:P19838|biolink:interacts_with|Parthenolide|NFKB1
3|ttd.drug:D0M4KE|UniProtKB:Q04864|biolink:interacts_with|Parthenolide|REL
4|ttd.drug:D0M4KE|UniProtKB:P19526|biolink:interacts_with|Parthenolide|GABRR1
5|ttd.drug:D08RUK|UniProtKB:P19838|biolink:interacts_with|PMID25553724-Compound-WO2011127048 31|NFKB1
6|ttd.drug:D08RUK|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-WO2011127048 31|REL
7|HP:0011113|HP:0011111|biolink:subclass_of|Abnormality of cytokine secretion|Abnormality of immune serum protein physiology
8|HP:0011113|HP:0033041|biolink:subclass_of|Abnormality of cytokine secretion|Cytokine storm
9|DRUGBANK:DB00005|UniProtKB:P19838|biolink:interacts_with||NFKB1
10|DRUGBANK:DB00005|UniProtKB:Q04864|biolink:interacts_with||REL
11|ttd.drug:D0Q2KK|UniProtKB:P19838|biolink:interacts_with|5H-6-thia-4,5-diaza-chrysene 6,6-dioxide|NFKB1
12|ttd.drug:D0Q2KK|UniProtKB:Q04864|biolink:interacts_with|5H-6-thia-4,5-diaza-chrysene 6,6-dioxide|REL
13|UniProtKB:P05231|DrugCentral:2245|biolink:molecularly_interacts_with|IL6|prednisolone
14|UniProtKB:P05231|DrugCentral:2351|biolink:molecularly_interacts_with|IL6|raloxifene
15|CORD:PMC7410831|HP:0002960|biolink:mentions|Landscape of cohesin-mediated chromatin loops in the human genome|Autoimmunity
16|CORD:PMC7410831|GO:0003682|biolink:mentions|Landscape of cohesin-mediated chromatin loops in the human genome|chromatin binding
17|ttd.drug:D05CGR|UniProtKB:P19838|biolink:interacts_with|PMID25553724-Compound-WO2013082253 31|NFKB1
18|ttd.drug:D05CGR|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-WO2013082253 31|REL
19|CORD:731b26ceffb7b60b94ca8ded21a774e46b2e8eca|GO:0003682|biolink:mentions|GFP: Lighting up life Mass spectrometry and its role in structural bi- ology|chromatin binding
20|CORD:731b26ceffb7b60b94ca8ded21a774e46b2e8eca|HP:0100806|biolink:mentions|GFP: Lighting up life Mass spectrometry and its role in structural bi- ology|Sepsis
21|CORD:731b26ceffb7b60b94ca8ded21a774e46b2e8eca|HP:0002960|biolink:mentions|GFP: Lighting up life Mass spectrometry and its role in structural bi- ology|Autoimmunity
22|CORD:PMC7122936|HP:0100806|biolink:mentions|Endogenous DAMPs, Category I: Constitutively Expressed, Native Molecules (Cat. I DAMPs)|Sepsis
23|CORD:PMC7122936|GO:0003682|biolink:mentions|Endogenous DAMPs, Category I: Constitutively Expressed, Native Molecules (Cat. I DAMPs)|chromatin binding
24|CORD:PMC7122936|HP:0002960|biolink:mentions|Endogenous DAMPs, Category I: Constitutively Expressed, Native Molecules (Cat. I DAMPs)|Autoimmunity
25|ttd.drug:D01NVL|UniProtKB:P19838|biolink:interacts_with|9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide|NFKB1
26|ttd.drug:D01NVL|UniProtKB:Q04864|biolink:interacts_with|9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide|REL
27|CORD:db4ea90206ddc3655ee91144046a1a84cc2b79f8|GO:0003682|biolink:mentions|Plenary talks O-001 View into the ribosomal exit tunnel|chromatin binding
28|CORD:db4ea90206ddc3655ee91144046a1a84cc2b79f8|HP:0002960|biolink:mentions|Plenary talks O-001 View into the ribosomal exit tunnel|Autoimmunity
29|ttd.drug:D02WOW|UniProtKB:P19838|biolink:interacts_with|PMID25553724-Compound-WO2011127048 32|NFKB1
30|ttd.drug:D02WOW|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-WO2011127048 32|REL
31|ttd.drug:D0Y0CA|UniProtKB:P19838|biolink:interacts_with|2-oxoguaia-1,4(15), 11(13)-trien-12,8beta-olide|NFKB1
32|ttd.drug:D0Y0CA|UniProtKB:Q04864|biolink:interacts_with|2-oxoguaia-1,4(15), 11(13)-trien-12,8beta-olide|REL
33|CORD:abf4edbbd5d8395de284a620e342d1cd524e3e4f|GO:0003682|biolink:mentions|Molecular Sciences Sickle Cell Disease: A Paradigm for Venous Thrombosis Pathophysiology|chromatin binding
34|CORD:abf4edbbd5d8395de284a620e342d1cd524e3e4f|HP:0100806|biolink:mentions|Molecular Sciences Sickle Cell Disease: A Paradigm for Venous Thrombosis Pathophysiology|Sepsis
35|ttd.drug:D04YTE|UniProtKB:P19838|biolink:interacts_with|ROCAGLAMIDE|NFKB1
36|ttd.drug:D04YTE|UniProtKB:Q04864|biolink:interacts_with|ROCAGLAMIDE|REL
37|ttd.drug:D00SRS|UniProtKB:P19838|biolink:interacts_with|BUDLEIN A|NFKB1
38|ttd.drug:D00SRS|UniProtKB:Q04864|biolink:interacts_with|BUDLEIN A|REL
39|CORD:1d474fdbea0e49794218cb044a52ee0778284acf|HP:0002960|biolink:mentions|EFFECTS OF ALLOPURINOL ON IN VIVO SUPPRESSION OF ARTHRITIS IN MICE AND EX VIVO MODULATION OF PHAGOCYTIC PRODUCTION OF OXYGEN RADICALS IN WHOLE HUMAN BLOOD|Autoimmunity
40|CORD:1d474fdbea0e49794218cb044a52ee0778284acf|GO:0003682|biolink:mentions|EFFECTS OF ALLOPURINOL ON IN VIVO SUPPRESSION OF ARTHRITIS IN MICE AND EX VIVO MODULATION OF PHAGOCYTIC PRODUCTION OF OXYGEN RADICALS IN WHOLE HUMAN BLOOD|chromatin binding
41|ttd.drug:D0Y0LD|UniProtKB:P19838|biolink:interacts_with|DTD|NFKB1
42|ttd.drug:D0Y0LD|UniProtKB:Q04864|biolink:interacts_with|DTD|REL
43|DrugCentral:391|UniProtKB:P19838|biolink:molecularly_interacts_with|bortezomib|NFKB1
44|DrugCentral:391|UniProtKB:V9HWD8|biolink:interacts_with|bortezomib|GABRR1
45|DrugCentral:391|UniProtKB:P19526|biolink:interacts_with|bortezomib|GABRR1
46|GO:0003682|UniProtKB:P03372|biolink:related_to|chromatin binding|ESR1
47|GO:0003682|GO:0003682|biolink:enabled_by|chromatin binding|chromatin binding
48|GO:0003682|CORD:PMC7105183|biolink:mentions|chromatin binding|The ubiquitous role of ubiquitin in the DNA damage response
49|GO:0003682|CORD:PMC7288346|biolink:mentions|chromatin binding|Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
50|GO:0003682|CORD:PMC7241096|biolink:mentions|chromatin binding|Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
51|GO:0003682|CORD:PMC7290766|biolink:mentions|chromatin binding|Innate Type 2 Responses to Respiratory Syncytial Virus Infection
52|GO:0003682|CORD:PMC7142273|biolink:mentions|chromatin binding|Forty Years of Basic and Translational Heparanase Research
53|GO:0003682|CORD:PMC4881129|biolink:mentions|chromatin binding|Epigenetic Effect of Environmental Factors on Autism Spectrum Disorders
54|GO:0003682|CORD:PMC7122125|biolink:mentions|chromatin binding|Role of Proteases in Inflammatory Lung Diseases
55|GO:0003682|CORD:PMC7432404|biolink:mentions|chromatin binding|Sickle Cell Disease: A Paradigm for Venous Thrombosis Pathophysiology
56|GO:0003682|CORD:PMC7482077|biolink:mentions|chromatin binding|Tandem Mass Tag-Based Quantitative Proteome Analysis of Porcine Deltacoronavirus (PDCoV)-Infected LLC Porcine Kidney Cells
57|GO:0003682|CORD:PMC7151907|biolink:mentions|chromatin binding|Intrinsic Cellular Defenses (TRIMS) in Modulating Viral Infection and Immunity
58|GO:0003682|CORD:PMC7203545|biolink:mentions|chromatin binding|Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
59|GO:0003682|CORD:PMC3252828|biolink:mentions|chromatin binding|HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells
60|GO:0003682|CORD:PMC7102569|biolink:mentions|chromatin binding|The involvement of regulated cell death forms in modulating the bacterial and viral pathogenesis
61|GO:0003682|CORD:PMC7322708|biolink:mentions|chromatin binding|The cholinergic anti-inflammatory pathway alleviates acute lung injury
62|GO:0003682|CORD:PMC4780752|biolink:mentions|chromatin binding|A new oxygen modification cyclooctaoxygen binds to nucleic acids as sodium crown complex
63|GO:0003682|CORD:PMC7255237|biolink:mentions|chromatin binding|Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese Medicine for respiratory tract infection?
64|GO:0003682|CORD:PMC7244094|biolink:mentions|chromatin binding|The hallmarks of COVID-19 disease
65|GO:0003682|CORD:PMC7341821|biolink:mentions|chromatin binding|A Genome-wide CRISPR Screen Reveals a Role for the Non-Canonical Nucleosome-Remodeling BAF Complex in Foxp3 Expression and Regulatory T Cell Function
66|GO:0003682|CORD:1401061f094876475ffffaa1c2284665ed6211e6|biolink:mentions|chromatin binding|The cholinergic anti-inflammatory pathway alleviates acute lung injury
67|GO:0003682|CORD:973360807c5c86a4b25979055e5308303d18e51b|biolink:mentions|chromatin binding|Tandem Mass Tag-Based Quantitative Proteome Analysis of Porcine Deltacoronavirus (PDCoV)-Infected LLC Porcine Kidney Cells
68|GO:0003682|CORD:6fa9233f054f4bbb31972e05c1478b0ec83ccc16|biolink:mentions|chromatin binding|viruses Innate Type 2 Responses to Respiratory Syncytial Virus Infection
69|GO:0003682|CORD:761f790316494707ee51902da33fc64a420458d2|biolink:mentions|chromatin binding|Intrinsic Cellular Defenses (TRIMS) in Modulating Viral Infection and Immunity
70|GO:0003682|CORD:46db8b3db38acf771fe27031fee9445b99146308|biolink:mentions|chromatin binding|Epigenetic Effect of Environmental Factors on Autism Spectrum Disorders
71|GO:0003682|CORD:67b6aa7293bbb9a8fed752ae0e96553f4f5c44aa|biolink:mentions|chromatin binding|Animal Proteomics www.proteomics-journal.com Label-Free Quantitative Proteomic Analysis of Differentially Expressed Membrane Proteins of Pulmonary Alveolar Macrophages Infected with Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus and Its Attenuated Strain
72|GO:0003682|CORD:7b2af34d3c65cc3eda82560616c424a447139709|biolink:mentions|chromatin binding|The involvement of regulated cell death forms in modulating the bacterial and viral pathogenesis
73|GO:0003682|CORD:931adf73488f9e9174fcac0a04810dcc10fdc563|biolink:mentions|chromatin binding|Landscape of cohesin-mediated chromatin loops in the human genome Open access Check for updates
74|GO:0003682|CORD:6586847495a654336f7b57200bcd5a1808e6cc98|biolink:mentions|chromatin binding|Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
75|GO:0003682|CORD:8d52c4f59211c5a60fc6f20593c787ad678ec953|biolink:mentions|chromatin binding|Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
76|GO:0003682|CORD:130a78592d496162b6584f9ed9b9ea3791a61ee7|biolink:mentions|chromatin binding|HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells
77|GO:0003682|CORD:ae9adf2e31d4b2c2e2b1577adbd1c3a68ee4ee35|biolink:mentions|chromatin binding|Deutsche Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie e.V
78|GO:0003682|CORD:f56a0a96e078af59e7e5ada5ebac1053a20e8f8f|biolink:mentions|chromatin binding|Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
79|GO:0003682|CORD:a47a74dba5021736b5c42030501bf11387b55d3c|biolink:mentions|chromatin binding|The hallmarks of COVID-19 disease
80|GO:0003682|CORD:2a080098ded8d0e968bac0ca8715dec8bbf109d3|biolink:mentions|chromatin binding|The ubiquitous role of ubiquitin in the DNA damage response
81|GO:0003682|CORD:aa44a2e3f0f2ae05b293fc84f970d889c6f72d72|biolink:mentions|chromatin binding|Molecular Sciences Histone H1 Post-Translational Modifications: Update and Future Perspectives
82|GO:0003682|CORD:bbfc4b79333018c0135f55544f7fddd5b8f1018a|biolink:mentions|chromatin binding|A new oxygen modification cyclooctaoxygen binds to nucleic acids as sodium crown complex
83|GO:0003682|CORD:a9719670ba12812aa1c4df175570c6bad4a9d336|biolink:mentions|chromatin binding|Thursday Orals O-001 Impaired Development of Early Endometriotic Lesions in CD 44
84|UniProtKB:P01375|DrugCentral:2616|biolink:molecularly_interacts_with|TNF|thalidomide
85|UniProtKB:P01375|UniProtKB:Q9Y572|biolink:related_to|TNF|ripk3_human
86|UniProtKB:P01375|DrugCentral:4904|biolink:molecularly_interacts_with|TNF|adalimumab
87|UniProtKB:P01375|DrugCentral:4967|biolink:molecularly_interacts_with|TNF|golimumab
88|UniProtKB:P01375|DrugCentral:4974|biolink:molecularly_interacts_with|TNF|infliximab
89|UniProtKB:P01375|DrugCentral:4978|biolink:molecularly_interacts_with|TNF|etanercept
90|UniProtKB:P01375|DrugCentral:5208|biolink:molecularly_interacts_with|TNF|plecanatide
91|ttd.drug:D09OGV|UniProtKB:P19838|biolink:interacts_with|PMID25553724-Compound-WO2011127048 34|NFKB1
92|ttd.drug:D09OGV|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-WO2011127048 34|REL
93|ttd.drug:D08JOY|UniProtKB:P19838|biolink:interacts_with|Avrina|NFKB1
94|ttd.drug:D08JOY|UniProtKB:Q04864|biolink:interacts_with|Avrina|REL
95|ttd.drug:D08UOY|UniProtKB:P19838|biolink:interacts_with|Vadimezan|NFKB1
96|ttd.drug:D08UOY|UniProtKB:Q04864|biolink:interacts_with|Vadimezan|REL
97|ttd.drug:D0N2GO|UniProtKB:P19838|biolink:interacts_with|7-hydroxycostunolide|NFKB1
98|ttd.drug:D0N2GO|UniProtKB:Q04864|biolink:interacts_with|7-hydroxycostunolide|REL
99|ttd.drug:D01LTK|UniProtKB:P19838|biolink:interacts_with|PMID25553724-Compound-WO2011152671 2|NFKB1
100|ttd.drug:D01LTK|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-WO2011152671 2|REL
101|ttd.drug:D0P1YO|UniProtKB:P19838|biolink:interacts_with|MOL-218|NFKB1
102|ttd.drug:D0P1YO|UniProtKB:Q04864|biolink:interacts_with|MOL-218|REL
103|DrugCentral:4967|UniProtKB:P19526|biolink:interacts_with|golimumab|GABRR1
104|ttd.drug:D0MY0M|UniProtKB:P19838|biolink:interacts_with|15-DEOXYBUDLEIN A|NFKB1
105|ttd.drug:D0MY0M|UniProtKB:Q04864|biolink:interacts_with|15-DEOXYBUDLEIN A|REL
106|ttd.drug:D09FBD|UniProtKB:P19838|biolink:interacts_with|MOLEPHANTIN|NFKB1
107|ttd.drug:D09FBD|UniProtKB:Q04864|biolink:interacts_with|MOLEPHANTIN|REL
108|DrugCentral:4825|UniProtKB:P19838|biolink:interacts_with|Laquinamod|NFKB1
109|DrugCentral:4825|UniProtKB:Q04864|biolink:interacts_with|Laquinamod|REL
110|DrugCentral:4825|UniProtKB:P19526|biolink:interacts_with|Laquinamod|GABRR1
111|UniProtKB:Q9BYF1|UniProtKB:P0DTC2|biolink:interacts_with|ACE2|S protein
112|UniProtKB:Q9BYF1|UniProtKB:P0DTC2|biolink:related_to|ACE2|S protein
113|UniProtKB:Q9BYF1|UniProtKB:Q9BYF1|biolink:interacts_with|ACE2|ACE2
114|ttd.drug:D02EHZ|UniProtKB:P19838|biolink:interacts_with|5-chloro-N-(quinolin-8-yl)thiophene-2-sulfonamide|NFKB1
115|ttd.drug:D02EHZ|UniProtKB:Q04864|biolink:interacts_with|5-chloro-N-(quinolin-8-yl)thiophene-2-sulfonamide|REL
116|ttd.drug:D0V4PJ|UniProtKB:P19838|biolink:interacts_with|9alpha-acetoxy-miller-1(10)Z-enolide|NFKB1
117|ttd.drug:D0V4PJ|UniProtKB:Q04864|biolink:interacts_with|9alpha-acetoxy-miller-1(10)Z-enolide|REL
118|ttd.drug:D01KHW|UniProtKB:P19838|biolink:interacts_with|CZEN-002|NFKB1
119|ttd.drug:D01KHW|UniProtKB:Q04864|biolink:interacts_with|CZEN-002|REL
120|ttd.drug:D0E7FU|UniProtKB:P19838|biolink:interacts_with|2-amino-N-(quinolin-8-yl)benzenesulfonamide|NFKB1
121|ttd.drug:D0E7FU|UniProtKB:Q04864|biolink:interacts_with|2-amino-N-(quinolin-8-yl)benzenesulfonamide|REL
122|ttd.drug:D07PWA|UniProtKB:P19838|biolink:interacts_with|IkappaB-alphaM|NFKB1
123|ttd.drug:D07PWA|UniProtKB:Q04864|biolink:interacts_with|IkappaB-alphaM|REL
124|ttd.drug:D0ED5S|UniProtKB:P19838|biolink:interacts_with|PMID25553724-Compound-US20130116324 2|NFKB1
125|ttd.drug:D0ED5S|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-US20130116324 2|REL
126|UniProtKB:Q9Y6K9|UniProtKB:P0DTD1-PRO_0000449631|biolink:interacts_with|IKBKG|nsp14
127|ttd.drug:D05RCK|UniProtKB:P19838|biolink:interacts_with|Miller-9E-enolide|NFKB1
128|ttd.drug:D05RCK|UniProtKB:Q04864|biolink:interacts_with|Miller-9E-enolide|REL
129|CORD:a9719670ba12812aa1c4df175570c6bad4a9d336|HP:0100806|biolink:mentions|Thursday Orals O-001 Impaired Development of Early Endometriotic Lesions in CD 44|Sepsis
130|CORD:a9719670ba12812aa1c4df175570c6bad4a9d336|HP:0002960|biolink:mentions|Thursday Orals O-001 Impaired Development of Early Endometriotic Lesions in CD 44|Autoimmunity
131|CORD:a9719670ba12812aa1c4df175570c6bad4a9d336|HP:0002958|biolink:mentions|Thursday Orals O-001 Impaired Development of Early Endometriotic Lesions in CD 44|Immune dysregulation
132|ttd.drug:D0LT6Z|UniProtKB:P19838|biolink:interacts_with|PMID25553724-Compound-US2012810604610|NFKB1
133|ttd.drug:D0LT6Z|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-US2012810604610|REL
134|ttd.drug:D0V5AL|UniProtKB:P19838|biolink:interacts_with|LC-1|NFKB1
135|ttd.drug:D0V5AL|UniProtKB:Q04864|biolink:interacts_with|LC-1|REL
136|DrugCentral:4904|UniProtKB:P19526|biolink:interacts_with|adalimumab|GABRR1
137|CORD:6fa9233f054f4bbb31972e05c1478b0ec83ccc16|HP:0002721|biolink:mentions|viruses Innate Type 2 Responses to Respiratory Syncytial Virus Infection|Immunodeficiency
138|ttd.drug:D0G8GL|UniProtKB:P19838|biolink:interacts_with|Miller-9Z-enolide|NFKB1
139|ttd.drug:D0G8GL|UniProtKB:Q04864|biolink:interacts_with|Miller-9Z-enolide|REL
140|CORD:2a080098ded8d0e968bac0ca8715dec8bbf109d3|HP:0002721|biolink:mentions|The ubiquitous role of ubiquitin in the DNA damage response|Immunodeficiency
141|CORD:130a78592d496162b6584f9ed9b9ea3791a61ee7|HP:0100806|biolink:mentions|HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells|Sepsis
142|CHEBI:46345|UniProtKB:O75469|biolink:interacts_with|5-fluorouracil|NR1I2
143|CHEBI:46345|UniProtKB:P19838|biolink:interacts_with|5-fluorouracil|NFKB1
144|ttd.drug:D05MJS|UniProtKB:P19838|biolink:interacts_with|PRO22 topical gel|NFKB1
145|ttd.drug:D05MJS|UniProtKB:Q04864|biolink:interacts_with|PRO22 topical gel|REL
146|ttd.drug:D0XU7R|UniProtKB:P19838|biolink:interacts_with|PMID25553724-Compound-US20138524747 3|NFKB1
147|ttd.drug:D0XU7R|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-US20138524747 3|REL
148|ttd.drug:D08NGV|UniProtKB:P19838|biolink:interacts_with|PMID25553724-Compound-US2012820715110|NFKB1
149|ttd.drug:D08NGV|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-US2012820715110|REL
150|ttd.drug:D00EOD|UniProtKB:P19838|biolink:interacts_with|CENTRATHERIN|NFKB1
151|ttd.drug:D00EOD|UniProtKB:Q04864|biolink:interacts_with|CENTRATHERIN|REL
152|CORD:PMC4881129|HP:0002958|biolink:mentions|Epigenetic Effect of Environmental Factors on Autism Spectrum Disorders|Immune dysregulation
153|CORD:PMC4881129|HP:0002721|biolink:mentions|Epigenetic Effect of Environmental Factors on Autism Spectrum Disorders|Immunodeficiency
154|ttd.drug:D01FYY|UniProtKB:P19838|biolink:interacts_with|SP-650003|NFKB1
155|ttd.drug:D01FYY|UniProtKB:Q04864|biolink:interacts_with|SP-650003|REL
156|DrugCentral:2451|UniProtKB:P19838|biolink:molecularly_interacts_with|sitosterol|NFKB1
157|DrugCentral:2451|UniProtKB:P19838|biolink:interacts_with|sitosterol|NFKB1
158|DrugCentral:2451|UniProtKB:P19526|biolink:interacts_with|sitosterol|GABRR1
159|DrugCentral:2451|UniProtKB:Q04864|biolink:interacts_with|sitosterol|REL
160|ttd.drug:D08JPU|UniProtKB:P19838|biolink:interacts_with|G6976|NFKB1
161|ttd.drug:D08JPU|UniProtKB:Q04864|biolink:interacts_with|G6976|REL
162|ttd.drug:D08JPU|UniProtKB:P19526|biolink:interacts_with|G6976|GABRR1
163|ttd.drug:D08JPU|UniProtKB:V9HWD8|biolink:interacts_with|G6976|GABRR1
164|ttd.drug:D0KO3I|UniProtKB:P19838|biolink:interacts_with|Olenolic acid acetate derivative 1|NFKB1
165|ttd.drug:D0KO3I|UniProtKB:Q04864|biolink:interacts_with|Olenolic acid acetate derivative 1|REL
166|DrugCentral:5208|UniProtKB:P19526|biolink:interacts_with|plecanatide|GABRR1
167|ttd.drug:D0V6QZ|UniProtKB:P19838|biolink:interacts_with|2-nitro-N-(quinolin-8-yl)benzenesulfonamide|NFKB1
168|ttd.drug:D0V6QZ|UniProtKB:Q04864|biolink:interacts_with|2-nitro-N-(quinolin-8-yl)benzenesulfonamide|REL
169|UniProtKB:V9HWD8|ttd.drug:D06TZZ|biolink:interacts_with|GABRR1|CAT 1004
170|UniProtKB:V9HWD8|ttd.drug:D0Q6YP|biolink:interacts_with|GABRR1|HELENALIN
171|UniProtKB:V9HWD8|DrugCentral:2351|biolink:interacts_with|GABRR1|raloxifene
172|ttd.drug:D0M6DV|UniProtKB:P19838|biolink:interacts_with|MOLEPHANTININ|NFKB1
173|ttd.drug:D0M6DV|UniProtKB:Q04864|biolink:interacts_with|MOLEPHANTININ|REL
174|DrugCentral:4978|UniProtKB:P19526|biolink:interacts_with|etanercept|GABRR1
175|CORD:PMC7288346|HP:0002960|biolink:mentions|Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability|Autoimmunity
176|ttd.drug:D08ZBD|UniProtKB:P19838|biolink:interacts_with|9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide|NFKB1
177|ttd.drug:D08ZBD|UniProtKB:Q04864|biolink:interacts_with|9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide|REL
178|UniProtKB:P0DTD1-PRO_0000449631|UniProtKB:Q04864|biolink:interacts_with|nsp14|REL
179|UniProtKB:P0DTD1-PRO_0000449631|UniProtKB:P0DTD1-PRO_0000449627|biolink:interacts_with|nsp14|nsp9
180|UniProtKB:P0DTD1-PRO_0000449631|GO:0019083|biolink:involved_in|nsp14|viral transcription
181|ttd.drug:D0Q5YJ|UniProtKB:P19838|biolink:interacts_with|PMID25553724-Compound-US2012819831110|NFKB1
182|ttd.drug:D0Q5YJ|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-US2012819831110|REL
183|ttd.drug:D05WCW|UniProtKB:P19838|biolink:interacts_with|Quinoxaline derivative 6|NFKB1
184|ttd.drug:D05WCW|UniProtKB:Q04864|biolink:interacts_with|Quinoxaline derivative 6|REL
185|UniProtKB:P19838|UniProtKB:O43318|biolink:related_to|NFKB1|MAP3K7
186|UniProtKB:P19838|DrugCentral:2525|biolink:interacts_with|NFKB1|sulfasalazine
187|UniProtKB:P19838|CHEBI:49668|biolink:interacts_with|NFKB1|gefitinib
188|UniProtKB:P19838|DRUGBANK:DB00762|biolink:interacts_with|NFKB1|
189|UniProtKB:P19838|DRUGBANK:DB00650|biolink:interacts_with|NFKB1|
190|UniProtKB:P19838|CHEBI:9316|biolink:interacts_with|NFKB1|sufentanil
191|UniProtKB:P19838|ttd.drug:D0Q6YP|biolink:interacts_with|NFKB1|HELENALIN
192|UniProtKB:P19838|ttd.drug:D03AJX|biolink:interacts_with|NFKB1|PS-341
193|UniProtKB:P19838|ttd.drug:D0R7UL|biolink:interacts_with|NFKB1|MD1003
194|UniProtKB:P19838|ttd.drug:D0I6LH|biolink:interacts_with|NFKB1|Triptolide
195|UniProtKB:P19838|ttd.drug:D06TZZ|biolink:interacts_with|NFKB1|CAT 1004
196|UniProtKB:P19838|ttd.drug:D0QR3X|biolink:interacts_with|NFKB1|Edasalonexent
197|UniProtKB:P19838|ttd.drug:D06HFI|biolink:interacts_with|NFKB1|L-ornithine phenylacetate
198|UniProtKB:P19838|ttd.drug:D00SBD|biolink:interacts_with|NFKB1|Recoflavone eye drops
199|UniProtKB:P19838|ttd.drug:D02RDX|biolink:interacts_with|NFKB1|XP-23829
200|UniProtKB:P19838|ttd.drug:D05UGL|biolink:interacts_with|NFKB1|1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 1
201|UniProtKB:P19838|ttd.drug:D0J2VS|biolink:interacts_with|NFKB1|1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 2
202|UniProtKB:P19838|ttd.drug:D00THJ|biolink:interacts_with|NFKB1|1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 3
203|UniProtKB:P19838|ttd.drug:D06YEK|biolink:interacts_with|NFKB1|1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 4
204|UniProtKB:P19838|ttd.drug:D03WHA|biolink:interacts_with|NFKB1|N-quinolin-benzene sulphonamide derivative 1
205|UniProtKB:P19838|ttd.drug:D0X2ZY|biolink:interacts_with|NFKB1|N-quinolin-benzene sulphonamide derivative 2
206|UniProtKB:P19838|ttd.drug:D04GMP|biolink:interacts_with|NFKB1|N-quinolin-benzene sulphonamide derivative 3
207|UniProtKB:P19838|ttd.drug:D07YSH|biolink:interacts_with|NFKB1|PMID25553724-Compound-EP20112308842 3
208|UniProtKB:P19838|ttd.drug:D07NCJ|biolink:interacts_with|NFKB1|PMID25553724-Compound-EP20132578214 2
209|UniProtKB:P19838|ttd.drug:D0E7ZN|biolink:interacts_with|NFKB1|PMID25553724-Compound-US2011000295210
210|UniProtKB:P19838|ttd.drug:D0PB4J|biolink:interacts_with|NFKB1|PMID25553724-Compound-US20110213001 3
211|UniProtKB:P19838|ttd.drug:D0Y2RN|biolink:interacts_with|NFKB1|PMID25553724-Compound-US2011788838110
212|UniProtKB:P19838|ttd.drug:D0BQ8A|biolink:interacts_with|NFKB1|PMID25553724-Compound-US2011796857710
213|UniProtKB:P19838|ttd.drug:D0BL3X|biolink:interacts_with|NFKB1|PMID25553724-Compound-US2011799419010
214|UniProtKB:P19838|ttd.drug:D0DL3R|biolink:interacts_with|NFKB1|PMID25553724-Compound-US2011801300410
215|UniProtKB:P19838|ttd.drug:D0GN7U|biolink:interacts_with|NFKB1|PMID25553724-Compound-US2011803494010
216|UniProtKB:P19838|ttd.drug:D0F9GL|biolink:interacts_with|NFKB1|PMID25553724-Compound-US2011806744710
217|UniProtKB:P19838|ttd.drug:D04NMJ|biolink:interacts_with|NFKB1|PMID25553724-Compound-US2012830453910
218|UniProtKB:P19838|ttd.drug:D0F5TR|biolink:interacts_with|NFKB1|PMID25553724-Compound-US2012832440110
219|UniProtKB:P19838|ttd.drug:D0D6DE|biolink:interacts_with|NFKB1|PMID25553724-Compound-US20138552206 4
220|UniProtKB:P19838|ttd.drug:D0R4RV|biolink:interacts_with|NFKB1|PMID25553724-Compound-US20138552206 5
221|UniProtKB:P19838|ttd.drug:D0P0KY|biolink:interacts_with|NFKB1|PMID25553724-Compound-WO2011127048 33
222|UniProtKB:P19838|ttd.drug:D0PB2J|biolink:interacts_with|NFKB1|PMID25553724-Compound-WO2013082253 32
223|UniProtKB:P19838|ttd.drug:D02CEY|biolink:interacts_with|NFKB1|PMID25553724-Compound-WO2013082253 33
224|UniProtKB:P19838|ttd.drug:D0K0TL|biolink:interacts_with|NFKB1|PMID25553724-Compound-WO2013082253 34
225|UniProtKB:P19838|ttd.drug:D09VXA|biolink:interacts_with|NFKB1|Quinoxaline derivative 1
226|UniProtKB:P19838|ttd.drug:D0O5TC|biolink:interacts_with|NFKB1|Quinoxaline derivative 2
227|UniProtKB:P19838|ttd.drug:D0Q6JK|biolink:interacts_with|NFKB1|Quinoxaline derivative 3
228|UniProtKB:P19838|ttd.drug:D0XQ5E|biolink:interacts_with|NFKB1|Quinoxaline derivative 4
229|UniProtKB:P19838|ttd.drug:D08YMD|biolink:interacts_with|NFKB1|Quinoxaline derivative 5
230|UniProtKB:P19838|ttd.drug:D0OY0Q|biolink:interacts_with|NFKB1|Tihotungstate derivative 1
231|UniProtKB:P19838|ttd.drug:D04NKE|biolink:interacts_with|NFKB1|Tihourea derivative 1
232|UniProtKB:P19838|ttd.drug:D03HVN|biolink:interacts_with|NFKB1|P-1
233|UniProtKB:P19838|ttd.drug:D0W7ZN|biolink:interacts_with|NFKB1|SIM-916
234|UniProtKB:P19838|ttd.drug:D0N1XD|biolink:interacts_with|NFKB1|Gliotoxin
235|UniProtKB:P19838|DrugCentral:4738|biolink:interacts_with|NFKB1|Tyloxapol
236|UniProtKB:P19838|ttd.drug:D06FRZ|biolink:interacts_with|NFKB1|15-ACETOXY-EREMANTHOLIDE B
237|UniProtKB:P19838|ttd.drug:D0VD3M|biolink:interacts_with|NFKB1|15-deoxygoiazensolide
238|UniProtKB:P19838|ttd.drug:D0J0ZF|biolink:interacts_with|NFKB1|15-isobutyrylmiguanin
239|UniProtKB:P19838|ttd.drug:D0B7EP|biolink:interacts_with|NFKB1|1beta-methoxy-miller-9Z-enolide
240|UniProtKB:P19838|ttd.drug:D06ZYQ|biolink:interacts_with|NFKB1|2beta-methoxy-2-deethoxyphantomolin
241|UniProtKB:P19838|ttd.drug:D0R2MO|biolink:interacts_with|NFKB1|2-oxoguaia-1,4,11(13)-trien-12,8alpha-olide
242|UniProtKB:P19838|ttd.drug:D0CQ5F|biolink:interacts_with|NFKB1|3,4-epoxydehydroleucodin
243|UniProtKB:P19838|ttd.drug:D00RAO|biolink:interacts_with|NFKB1|4,5-ISOBUDLEIN A
244|UniProtKB:P19838|ttd.drug:D0B8RN|biolink:interacts_with|NFKB1|4beta,15-epoxy-miller-9E-enolide
245|UniProtKB:P19838|ttd.drug:D0F7UW|biolink:interacts_with|NFKB1|4beta,15-epoxy-miller-9Z-enolide
246|UniProtKB:P19838|ttd.drug:D05OPF|biolink:interacts_with|NFKB1|4-nitro-N-(quinolin-8-yl)benzenesulfonamide
247|UniProtKB:P19838|ttd.drug:D04VQM|biolink:interacts_with|NFKB1|5-bromo-N-(quinolin-8-yl)thiophene-2-sulfonamide
248|UniProtKB:P19838|ttd.drug:D08KJM|biolink:interacts_with|NFKB1|9-methyl-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide
249|UniProtKB:P19838|ttd.drug:D0F0VD|biolink:interacts_with|NFKB1|ACHP
250|UniProtKB:P19838|ttd.drug:D0J2PO|biolink:interacts_with|NFKB1|ARTOBILOXANTHONE
251|UniProtKB:P19838|ttd.drug:D07JDD|biolink:interacts_with|NFKB1|ARTORIGIDIN A
252|UniProtKB:P19838|ttd.drug:D06MAL|biolink:interacts_with|NFKB1|ATRIPLICIOLIDTIGLATE
253|UniProtKB:P19838|ttd.drug:D0L2XO|biolink:interacts_with|NFKB1|BAY11-7082
254|UniProtKB:P19838|ttd.drug:D06YGF|biolink:interacts_with|NFKB1|Caffeic acid phenethyl ester
255|UniProtKB:P19838|ttd.drug:D0J7XB|biolink:interacts_with|NFKB1|ENHYDRIN
256|UniProtKB:P19838|ttd.drug:D0O5HF|biolink:interacts_with|NFKB1|Helenalin-2-methylbutyrate
257|UniProtKB:P19838|ttd.drug:D05DHX|biolink:interacts_with|NFKB1|HELENALINMETHACRYLATE
258|UniProtKB:P19838|ttd.drug:D0LH9A|biolink:interacts_with|NFKB1|ISOGOIAZENSOLIDE
259|UniProtKB:P19838|ttd.drug:D03VYU|biolink:interacts_with|NFKB1|Isohelenin
260|UniProtKB:P19838|ttd.drug:D0X8OL|biolink:interacts_with|NFKB1|N-(quinolin-8-yl)thiophene-2-sulfonamide
261|UniProtKB:P19838|ttd.drug:D00OQW|biolink:interacts_with|NFKB1|N-acetylcysteine
262|UniProtKB:P19838|ttd.drug:D07MQC|biolink:interacts_with|NFKB1|PS-1145
263|UniProtKB:P19838|ttd.drug:D09SZJ|biolink:interacts_with|NFKB1|Pycnogenol
264|UniProtKB:P19838|ttd.drug:D0B0IJ|biolink:interacts_with|NFKB1|Pyrrolidine dithiocarbamate
265|UniProtKB:P19838|ttd.drug:D06ZIE|biolink:interacts_with|NFKB1|SCANDENOLIDE
266|UniProtKB:P03372|DrugCentral:2351|biolink:molecularly_interacts_with|ESR1|raloxifene
267|HP:0011111|HP:0010978|biolink:subclass_of|Abnormality of immune serum protein physiology|Abnormality of immune system physiology
268|ttd.drug:D0K0TL|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-WO2013082253 34|REL
269|ttd.drug:D04NMJ|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-US2012830453910|REL
270|ttd.drug:D08KJM|UniProtKB:Q04864|biolink:interacts_with|9-methyl-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide|REL
271|CORD:a47a74dba5021736b5c42030501bf11387b55d3c|HP:0002715|biolink:mentions|The hallmarks of COVID-19 disease|Abnormality of the immune system
272|CORD:a47a74dba5021736b5c42030501bf11387b55d3c|HP:0100806|biolink:mentions|The hallmarks of COVID-19 disease|Sepsis
273|CORD:a47a74dba5021736b5c42030501bf11387b55d3c|HP:0002960|biolink:mentions|The hallmarks of COVID-19 disease|Autoimmunity
274|CORD:a47a74dba5021736b5c42030501bf11387b55d3c|HP:0002958|biolink:mentions|The hallmarks of COVID-19 disease|Immune dysregulation
275|CORD:a47a74dba5021736b5c42030501bf11387b55d3c|HP:0002721|biolink:mentions|The hallmarks of COVID-19 disease|Immunodeficiency
276|ttd.drug:D07NCJ|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-EP20132578214 2|REL
277|ttd.drug:D0J2PO|UniProtKB:Q04864|biolink:interacts_with|ARTOBILOXANTHONE|REL
278|DRUGBANK:DB00762|UniProtKB:O75469|biolink:interacts_with||NR1I2
279|CHEBI:9316|UniProtKB:Q04864|biolink:interacts_with|sufentanil|REL
280|HP:0100806|CORD:PMC7432404|biolink:mentions|Sepsis|Sickle Cell Disease: A Paradigm for Venous Thrombosis Pathophysiology
281|HP:0100806|CORD:8d52c4f59211c5a60fc6f20593c787ad678ec953|biolink:mentions|Sepsis|Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
282|HP:0100806|CORD:PMC7142273|biolink:mentions|Sepsis|Forty Years of Basic and Translational Heparanase Research
283|HP:0100806|CORD:PMC7322708|biolink:mentions|Sepsis|The cholinergic anti-inflammatory pathway alleviates acute lung injury
284|HP:0100806|CORD:1401061f094876475ffffaa1c2284665ed6211e6|biolink:mentions|Sepsis|The cholinergic anti-inflammatory pathway alleviates acute lung injury
285|HP:0100806|CORD:PMC7244094|biolink:mentions|Sepsis|The hallmarks of COVID-19 disease
286|HP:0100806|CORD:ae9adf2e31d4b2c2e2b1577adbd1c3a68ee4ee35|biolink:mentions|Sepsis|Deutsche Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie e.V
287|HP:0100806|CORD:PMC7203545|biolink:mentions|Sepsis|Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
288|HP:0100806|CORD:PMC7241096|biolink:mentions|Sepsis|Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
289|HP:0100806|CORD:PMC3252828|biolink:mentions|Sepsis|HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells
290|HP:0100806|CORD:f56a0a96e078af59e7e5ada5ebac1053a20e8f8f|biolink:mentions|Sepsis|Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
291|HP:0100806|HP:0010978|biolink:subclass_of|Sepsis|Abnormality of immune system physiology
292|HP:0100806|CORD:PMC7122125|biolink:mentions|Sepsis|Role of Proteases in Inflammatory Lung Diseases
293|HP:0002960|CORD:PMC7255237|biolink:mentions|Autoimmunity|Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese Medicine for respiratory tract infection?
294|HP:0002960|CORD:761f790316494707ee51902da33fc64a420458d2|biolink:mentions|Autoimmunity|Intrinsic Cellular Defenses (TRIMS) in Modulating Viral Infection and Immunity
295|HP:0002960|CORD:PMC7142273|biolink:mentions|Autoimmunity|Forty Years of Basic and Translational Heparanase Research
296|HP:0002960|CORD:PMC7341821|biolink:mentions|Autoimmunity|A Genome-wide CRISPR Screen Reveals a Role for the Non-Canonical Nucleosome-Remodeling BAF Complex in Foxp3 Expression and Regulatory T Cell Function
297|HP:0002960|CORD:aa44a2e3f0f2ae05b293fc84f970d889c6f72d72|biolink:mentions|Autoimmunity|Molecular Sciences Histone H1 Post-Translational Modifications: Update and Future Perspectives
298|HP:0002960|CORD:6586847495a654336f7b57200bcd5a1808e6cc98|biolink:mentions|Autoimmunity|Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
299|HP:0002960|CORD:ae9adf2e31d4b2c2e2b1577adbd1c3a68ee4ee35|biolink:mentions|Autoimmunity|Deutsche Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie e.V
300|HP:0002960|CORD:67b6aa7293bbb9a8fed752ae0e96553f4f5c44aa|biolink:mentions|Autoimmunity|Animal Proteomics www.proteomics-journal.com Label-Free Quantitative Proteomic Analysis of Differentially Expressed Membrane Proteins of Pulmonary Alveolar Macrophages Infected with Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus and Its Attenuated Strain
301|HP:0002960|CORD:931adf73488f9e9174fcac0a04810dcc10fdc563|biolink:mentions|Autoimmunity|Landscape of cohesin-mediated chromatin loops in the human genome Open access Check for updates
302|HP:0002960|HP:0010978|biolink:subclass_of|Autoimmunity|Abnormality of immune system physiology
303|HP:0002960|CORD:PMC7151907|biolink:mentions|Autoimmunity|Intrinsic Cellular Defenses (TRIMS) in Modulating Viral Infection and Immunity
304|ttd.drug:D0Q6JK|UniProtKB:Q04864|biolink:interacts_with|Quinoxaline derivative 3|REL
305|ttd.drug:D0J7XB|UniProtKB:Q04864|biolink:interacts_with|ENHYDRIN|REL
306|ttd.drug:D03AJX|UniProtKB:Q04864|biolink:interacts_with|PS-341|REL
307|UniProtKB:O43318|UniProtKB:Q9Y572|biolink:related_to|MAP3K7|ripk3_human
308|ttd.drug:D0F9GL|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-US2011806744710|REL
309|ttd.drug:D07JDD|UniProtKB:Q04864|biolink:interacts_with|ARTORIGIDIN A|REL
310|HP:0002715|CORD:PMC7244094|biolink:mentions|Abnormality of the immune system|The hallmarks of COVID-19 disease
311|HP:0002715|HP:0010978|biolink:subclass_of|Abnormality of the immune system|Abnormality of immune system physiology
312|ttd.drug:D0PB2J|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-WO2013082253 32|REL
313|ttd.drug:D0OY0Q|UniProtKB:Q04864|biolink:interacts_with|Tihotungstate derivative 1|REL
314|CORD:761f790316494707ee51902da33fc64a420458d2|GO:0019083|biolink:mentions|Intrinsic Cellular Defenses (TRIMS) in Modulating Viral Infection and Immunity|viral transcription
315|ttd.drug:D09SZJ|UniProtKB:Q04864|biolink:interacts_with|Pycnogenol|REL
316|DrugCentral:2616|UniProtKB:P19526|biolink:interacts_with|thalidomide|GABRR1
317|ttd.drug:D0E7ZN|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-US2011000295210|REL
318|ttd.drug:D0D6DE|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-US20138552206 4|REL
319|UniProtKB:O75469|DrugCentral:2351|biolink:molecularly_interacts_with|NR1I2|raloxifene
320|UniProtKB:O75469|DRUGBANK:DB00650|biolink:interacts_with|NR1I2|
321|ttd.drug:D0LH9A|UniProtKB:Q04864|biolink:interacts_with|ISOGOIAZENSOLIDE|REL
322|DrugCentral:2245|UniProtKB:P19526|biolink:interacts_with|prednisolone|GABRR1
323|ttd.drug:D0O5HF|UniProtKB:Q04864|biolink:interacts_with|Helenalin-2-methylbutyrate|REL
324|ttd.drug:D0F7UW|UniProtKB:Q04864|biolink:interacts_with|4beta,15-epoxy-miller-9Z-enolide|REL
325|ttd.drug:D03HVN|UniProtKB:Q04864|biolink:interacts_with|P-1|REL
326|ttd.drug:D06ZYQ|UniProtKB:Q04864|biolink:interacts_with|2beta-methoxy-2-deethoxyphantomolin|REL
327|HP:0002958|CORD:PMC7244094|biolink:mentions|Immune dysregulation|The hallmarks of COVID-19 disease
328|HP:0002958|HP:0010978|biolink:subclass_of|Immune dysregulation|Abnormality of immune system physiology
329|HP:0002958|CORD:46db8b3db38acf771fe27031fee9445b99146308|biolink:mentions|Immune dysregulation|Epigenetic Effect of Environmental Factors on Autism Spectrum Disorders
330|CORD:PMC7244094|HP:0002721|biolink:mentions|The hallmarks of COVID-19 disease|Immunodeficiency
331|ttd.drug:D03WHA|UniProtKB:Q04864|biolink:interacts_with|N-quinolin-benzene sulphonamide derivative 1|REL
332|ttd.drug:D0N1XD|UniProtKB:Q04864|biolink:interacts_with|Gliotoxin|REL
333|ttd.drug:D0X8OL|UniProtKB:Q04864|biolink:interacts_with|N-(quinolin-8-yl)thiophene-2-sulfonamide|REL
334|CORD:bbfc4b79333018c0135f55544f7fddd5b8f1018a|HP:0002721|biolink:mentions|A new oxygen modification cyclooctaoxygen binds to nucleic acids as sodium crown complex|Immunodeficiency
335|ttd.drug:D06ZIE|UniProtKB:Q04864|biolink:interacts_with|SCANDENOLIDE|REL
336|ttd.drug:D05DHX|UniProtKB:Q04864|biolink:interacts_with|HELENALINMETHACRYLATE|REL
337|DrugCentral:2525|UniProtKB:P19526|biolink:interacts_with|sulfasalazine|GABRR1
338|DrugCentral:2525|UniProtKB:Q04864|biolink:interacts_with|sulfasalazine|REL
339|ttd.drug:D06TZZ|UniProtKB:Q04864|biolink:interacts_with|CAT 1004|REL
340|ttd.drug:D06TZZ|UniProtKB:P19526|biolink:interacts_with|CAT 1004|GABRR1
341|GO:0019083|GO:0039696|biolink:subclass_of|viral transcription|RNA-templated viral transcription
342|GO:0019083|CORD:PMC7151907|biolink:mentions|viral transcription|Intrinsic Cellular Defenses (TRIMS) in Modulating Viral Infection and Immunity
343|ttd.drug:D0B7EP|UniProtKB:Q04864|biolink:interacts_with|1beta-methoxy-miller-9Z-enolide|REL
344|ttd.drug:D00SBD|UniProtKB:Q04864|biolink:interacts_with|Recoflavone eye drops|REL
345|CHEBI:49668|UniProtKB:Q04864|biolink:interacts_with|gefitinib|REL
346|ttd.drug:D0Q6YP|UniProtKB:P19526|biolink:interacts_with|HELENALIN|GABRR1
347|ttd.drug:D0Q6YP|UniProtKB:Q04864|biolink:interacts_with|HELENALIN|REL
348|DrugCentral:4738|UniProtKB:Q04864|biolink:interacts_with|Tyloxapol|REL
349|ttd.drug:D09VXA|UniProtKB:Q04864|biolink:interacts_with|Quinoxaline derivative 1|REL
350|ttd.drug:D05OPF|UniProtKB:Q04864|biolink:interacts_with|4-nitro-N-(quinolin-8-yl)benzenesulfonamide|REL
351|ttd.drug:D0J2VS|UniProtKB:Q04864|biolink:interacts_with|1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 2|REL
352|DrugCentral:4974|UniProtKB:P19526|biolink:interacts_with|infliximab|GABRR1
353|UniProtKB:P0DTD1-PRO_0000449627|UniProtKB:Q04864|biolink:interacts_with|nsp9|REL
354|UniProtKB:P0DTD1-PRO_0000449627|GO:0039694|biolink:involved_in|nsp9|viral RNA genome replication
355|UniProtKB:P0DTD1-PRO_0000449627|UniProtKB:P0DTC2|biolink:interacts_with|nsp9|S protein
356|ttd.drug:D0F5TR|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-US2012832440110|REL
357|ttd.drug:D0I6LH|UniProtKB:Q04864|biolink:interacts_with|Triptolide|REL
358|ttd.drug:D0PB4J|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-US20110213001 3|REL
359|ttd.drug:D06HFI|UniProtKB:Q04864|biolink:interacts_with|L-ornithine phenylacetate|REL
360|ttd.drug:D0DL3R|UniProtKB:Q04864|biolink:interacts_with|PMID25553724-Compound-US2011801300410|REL
361|UniProtKB:P19526|DrugCentral:2351|biolink:interacts_with|GABRR1|raloxifene
362|CORD:ae9adf2e31d4b2c2e2b1577adbd1c3a68ee4ee35|HP:0002721|biolink:mentions|Deutsche Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie e.V|Immunodeficiency
363|ttd.drug:D0J0ZF|UniProtKB:Q04864|biolink:interacts_with|15-isobutyrylmiguanin|REL
364|UniProtKB:P0DTC2|UniProtKB:P0DTC2|biolink:interacts_with|S protein|S protein
365|ttd.drug:D0X2ZY|UniProtKB:Q04864|biolink:interacts_with|N-quinolin-benzene sulphonamide derivative 2|REL
366|ttd.drug:D00THJ|UniProtKB:Q04864|biolink:interacts_with|1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 3|REL
367|UniProtKB:Q04864|ttd.drug:D0R7UL|biolink:interacts_with|REL|MD1003
368|UniProtKB:Q04864|ttd.drug:D0QR3X|biolink:interacts_with|REL|Edasalonexent
369|UniProtKB:Q04864|ttd.drug:D02RDX|biolink:interacts_with|REL|XP-23829
370|UniProtKB:Q04864|ttd.drug:D05UGL|biolink:interacts_with|REL|1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 1
371|UniProtKB:Q04864|ttd.drug:D06YEK|biolink:interacts_with|REL|1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 4
372|UniProtKB:Q04864|ttd.drug:D04GMP|biolink:interacts_with|REL|N-quinolin-benzene sulphonamide derivative 3
373|UniProtKB:Q04864|ttd.drug:D07YSH|biolink:interacts_with|REL|PMID25553724-Compound-EP20112308842 3
374|UniProtKB:Q04864|ttd.drug:D0Y2RN|biolink:interacts_with|REL|PMID25553724-Compound-US2011788838110
375|UniProtKB:Q04864|ttd.drug:D0BQ8A|biolink:interacts_with|REL|PMID25553724-Compound-US2011796857710
376|UniProtKB:Q04864|ttd.drug:D0BL3X|biolink:interacts_with|REL|PMID25553724-Compound-US2011799419010
377|UniProtKB:Q04864|ttd.drug:D0GN7U|biolink:interacts_with|REL|PMID25553724-Compound-US2011803494010
378|UniProtKB:Q04864|ttd.drug:D0R4RV|biolink:interacts_with|REL|PMID25553724-Compound-US20138552206 5
379|UniProtKB:Q04864|ttd.drug:D0P0KY|biolink:interacts_with|REL|PMID25553724-Compound-WO2011127048 33
380|UniProtKB:Q04864|ttd.drug:D02CEY|biolink:interacts_with|REL|PMID25553724-Compound-WO2013082253 33
381|UniProtKB:Q04864|ttd.drug:D0O5TC|biolink:interacts_with|REL|Quinoxaline derivative 2
382|UniProtKB:Q04864|ttd.drug:D0XQ5E|biolink:interacts_with|REL|Quinoxaline derivative 4
383|UniProtKB:Q04864|ttd.drug:D08YMD|biolink:interacts_with|REL|Quinoxaline derivative 5
384|UniProtKB:Q04864|ttd.drug:D04NKE|biolink:interacts_with|REL|Tihourea derivative 1
385|UniProtKB:Q04864|ttd.drug:D0W7ZN|biolink:interacts_with|REL|SIM-916
386|UniProtKB:Q04864|ttd.drug:D06FRZ|biolink:interacts_with|REL|15-ACETOXY-EREMANTHOLIDE B
387|UniProtKB:Q04864|ttd.drug:D0VD3M|biolink:interacts_with|REL|15-deoxygoiazensolide
388|UniProtKB:Q04864|ttd.drug:D0R2MO|biolink:interacts_with|REL|2-oxoguaia-1,4,11(13)-trien-12,8alpha-olide
389|UniProtKB:Q04864|ttd.drug:D0CQ5F|biolink:interacts_with|REL|3,4-epoxydehydroleucodin
390|UniProtKB:Q04864|ttd.drug:D00RAO|biolink:interacts_with|REL|4,5-ISOBUDLEIN A
391|UniProtKB:Q04864|ttd.drug:D0B8RN|biolink:interacts_with|REL|4beta,15-epoxy-miller-9E-enolide
392|UniProtKB:Q04864|ttd.drug:D04VQM|biolink:interacts_with|REL|5-bromo-N-(quinolin-8-yl)thiophene-2-sulfonamide
393|UniProtKB:Q04864|ttd.drug:D0F0VD|biolink:interacts_with|REL|ACHP
394|UniProtKB:Q04864|ttd.drug:D06MAL|biolink:interacts_with|REL|ATRIPLICIOLIDTIGLATE
395|UniProtKB:Q04864|ttd.drug:D0L2XO|biolink:interacts_with|REL|BAY11-7082
396|UniProtKB:Q04864|ttd.drug:D06YGF|biolink:interacts_with|REL|Caffeic acid phenethyl ester
397|UniProtKB:Q04864|ttd.drug:D03VYU|biolink:interacts_with|REL|Isohelenin
398|UniProtKB:Q04864|ttd.drug:D00OQW|biolink:interacts_with|REL|N-acetylcysteine
399|UniProtKB:Q04864|ttd.drug:D07MQC|biolink:interacts_with|REL|PS-1145
400|UniProtKB:Q04864|ttd.drug:D0B0IJ|biolink:interacts_with|REL|Pyrrolidine dithiocarbamate
401|CORD:PMC4780752|HP:0002721|biolink:mentions|A new oxygen modification cyclooctaoxygen binds to nucleic acids as sodium crown complex|Immunodeficiency
402|CORD:973360807c5c86a4b25979055e5308303d18e51b|HP:0002721|biolink:mentions|Tandem Mass Tag-Based Quantitative Proteome Analysis of Porcine Deltacoronavirus (PDCoV)-Infected LLC Porcine Kidney Cells|Immunodeficiency
403|GO:0039694|GO:0039691|biolink:subclass_of|viral RNA genome replication|double stranded viral RNA replication
404|GO:0039691|GO:0039696|biolink:has_part|double stranded viral RNA replication|RNA-templated viral transcription
405|HP:0010978|HP:0002721|biolink:subclass_of|Abnormality of immune system physiology|Immunodeficiency
406|CORD:PMC7290766|HP:0002721|biolink:mentions|Innate Type 2 Responses to Respiratory Syncytial Virus Infection|Immunodeficiency
407|HP:0002721|CORD:PMC7102569|biolink:mentions|Immunodeficiency|The involvement of regulated cell death forms in modulating the bacterial and viral pathogenesis
408|HP:0002721|CORD:46db8b3db38acf771fe27031fee9445b99146308|biolink:mentions|Immunodeficiency|Epigenetic Effect of Environmental Factors on Autism Spectrum Disorders
409|HP:0002721|CORD:7b2af34d3c65cc3eda82560616c424a447139709|biolink:mentions|Immunodeficiency|The involvement of regulated cell death forms in modulating the bacterial and viral pathogenesis
410|HP:0002721|CORD:PMC7105183|biolink:mentions|Immunodeficiency|The ubiquitous role of ubiquitin in the DNA damage response
411|HP:0002721|CORD:PMC7482077|biolink:mentions|Immunodeficiency|Tandem Mass Tag-Based Quantitative Proteome Analysis of Porcine Deltacoronavirus (PDCoV)-Infected LLC Porcine Kidney Cells
